UB Paderborn / Katalog / Suche / in CDI

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1680-1689

2015

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.117-127

2021

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Journal of global antimicrobial resistance., 2021-12, Vol.27, p.337-351

2021

Link zum Volltext

Verfügbarkeit prüfen

Dissemination of a pSCFS3-Like cfr-Carrying Plasmid in Staphylococcus aureus and Staphylococcus epidermidis Clinical Isolates Recovered from Hospitals in Ohio

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.2923-2928

2013

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme

International journal of antimicrobial agents, 2018-08, Vol.52 (2), p.144-150

2018

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018

Journal of global antimicrobial resistance., 2021-06, Vol.25, p.14-17

2021

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resistant Gram-Positive and Fastidious Organism Groups

Antimicrobial Agents and Chemotherapy, 2007-04, Vol.51 (4), p.1191-1201

2007

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing

Antimicrobial agents and chemotherapy, 2018-07, Vol.62 (7)

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.6381-6385

2016

Link zum Volltext

Verfügbarkeit prüfen

Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0221321-e0221321

2023

Link zum Volltext

Verfügbarkeit prüfen

Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019

Antimicrobial agents and chemotherapy, 2022-01, Vol.66 (1), p.e0139721-e0139721

2022

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017

Journal of global antimicrobial resistance., 2019-12, Vol.19, p.56-63

2019

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)

Antimicrobial agents and chemotherapy, 2019-03, Vol.63 (3)

2019

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)

International journal of antimicrobial agents, 2018-06, Vol.51 (6), p.848-853

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1478-1486

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2537-2541

2016

Link zum Volltext

Verfügbarkeit prüfen

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.467-474

2015

Link zum Volltext

Verfügbarkeit prüfen

In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3627-3629

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Dissemination of a pSCFS3-Like cfr-Carrying Plasmid in Staphylococcus aureus and Staphylococcus epidermidis Clinical Isolates Recovered from Hospitals in Ohio

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme

In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018

In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resistant Gram-Positive and Fastidious Organism Groups

A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing

In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019

Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017

Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)

Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)

Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae

In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates

In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria

In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas

Aktive Filter

Suchergebnisse filtern